272 related articles for article (PubMed ID: 33013936)
1. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections.
Münz C
Front Immunol; 2020; 11():581419. PubMed ID: 33013936
[TBL] [Abstract][Full Text] [Related]
2. Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components.
Münz C
Front Immunol; 2018; 9():238. PubMed ID: 29483919
[TBL] [Abstract][Full Text] [Related]
3. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
[TBL] [Abstract][Full Text] [Related]
4. KSHV infection of B cells primes protective T cell responses in humanized mice.
Caduff N; Rieble L; Böni M; McHugh D; Roshan R; Miley W; Labo N; Barman S; Trivett M; Bosma DMT; Rühl J; Goebels N; Whitby D; Münz C
Nat Commun; 2024 Jun; 15(1):4841. PubMed ID: 38844783
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T cell immunity to Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.
Hislop AD; Sabbah S
Semin Cancer Biol; 2008 Dec; 18(6):416-22. PubMed ID: 19007888
[TBL] [Abstract][Full Text] [Related]
6. Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.
McHugh D; Caduff N; Murer A; Engelmann C; Deng Y; Zdimerova H; Zens K; Chijioke O; Münz C
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180296. PubMed ID: 30955487
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses.
Münz C
Viruses; 2021 May; 13(5):. PubMed ID: 34066671
[TBL] [Abstract][Full Text] [Related]
8. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.
Damania B; Münz C
FEMS Microbiol Rev; 2019 Mar; 43(2):181-192. PubMed ID: 30649299
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
10. Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
Böni M; Rieble L; Münz C
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560713
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB signaling modulation by EBV and KSHV.
de Oliveira DE; Ballon G; Cesarman E
Trends Microbiol; 2010 Jun; 18(6):248-57. PubMed ID: 20452220
[TBL] [Abstract][Full Text] [Related]
12. Immune mechanisms in murine gammaherpesvirus-68 infection.
Stevenson PG; Efstathiou S
Viral Immunol; 2005; 18(3):445-56. PubMed ID: 16212523
[TBL] [Abstract][Full Text] [Related]
13. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
Cirone M
Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
[TBL] [Abstract][Full Text] [Related]
14. [EBV/KSHV co-infection: an effective partnership].
Gruffat H; Manet E
Med Sci (Paris); 2018 Jan; 34(1):79-82. PubMed ID: 29384100
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoints in T cells during oncogenic γ-herpesvirus infections.
Münz C
J Med Virol; 2023 Jan; 95(1):e27840. PubMed ID: 35524342
[TBL] [Abstract][Full Text] [Related]
16. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection.
Caduff N; McHugh D; Rieble L; Forconi CS; Ong'echa JM; Oluoch PO; Raykova A; Murer A; Böni M; Zuppiger L; Schulz TF; Blackbourn DJ; Chijioke O; Moormann AM; Münz C
Cell Rep; 2021 May; 35(5):109056. PubMed ID: 33951431
[TBL] [Abstract][Full Text] [Related]
17. Humanized mouse models for Epstein Barr virus infection.
Münz C
Curr Opin Virol; 2017 Aug; 25():113-118. PubMed ID: 28837889
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity in Epstein Barr virus specific immune control.
Münz C
Curr Opin Virol; 2021 Feb; 46():1-8. PubMed ID: 32771660
[TBL] [Abstract][Full Text] [Related]
19. Double the Trouble When Herpesviruses Join Hands.
Choi UY; Park A; Jung JU
Cell Host Microbe; 2017 Jul; 22(1):5-7. PubMed ID: 28704653
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell responses to human oncogenic γ-herpesvirus infections.
Münz C
Semin Immunol; 2022 Mar; 60():101652. PubMed ID: 36162228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
